47 results
S-3
EX-1.2
LYEL
Lyell Immunopharma, Inc.
28 Feb 24
Shelf registration
7:49pm
material respects in the Prospectus. The description of the Company’s stock option, stock bonus and other stock plans or arrangements … , stock option, stock bonus, employee stock purchase or other stock plan or arrangement described in the Prospectus, (ii) the issuance of securities
8-K
661vvtq 0u
6 Jun 23
Departure of Directors or Certain Officers
4:02pm
8-K
f99zt nmo9pd
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
8-K
EX-10.1
gs0y fsi59fxd3
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
8-K
EX-10.2
zj7nut
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
DEF 14A
r4hlt54rzib9
28 Apr 22
Definitive proxy
4:11pm
10-K
EX-10.8
w5sgmps3w70aa9oazbn
29 Mar 22
Annual report
4:20pm
8-K
vgaw0ejqd
15 Feb 22
Departure of Directors or Certain Officers
4:47pm
8-K
revpk77g wto1ua8nue
28 Oct 21
Departure of Directors or Certain Officers
12:00am
S-8
EX-99.3
719htgpzj 7kearh
21 Jun 21
Registration of securities for employees
5:08pm